New strategies in achieving antiangiogenic effect: Multiplex inhibitors suppressing compensatory activations of RTKs

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Pathological angiogenesis is critical in malignant neoplasia.
• Vascular normalization enhances chemotherapy efficacy but is often hindered by compensatory activation of alternative receptor tyrosine kinases (RTKs).
• Angiogenesis complexity and heterogeneity challenge single-target therapies.

Purpose of the Study:

• To review recent progress in developing multiplex inhibitors of angiogenesis.
• To highlight the strategy of multiplex RTK inhibition for enhanced cancer treatment.
• To discuss the development of inhibitors targeting VEGFR-2/Tie-2/EphB4.

Main Methods:

• Review of recent scientific literature on angiogenesis inhibitors.
• Analysis of the multiplex inhibition strategy based on vascular normalization.
• Focus on inhibitors targeting conserved ATP-binding pockets of VEGFR-2, Tie-2, and EphB4.

Main Results:

• Multiplex RTK inhibition can enhance treatment efficacy and overcome resistance.
• Targeting VEGFR-2/Tie-2/EphB4 is feasible due to conserved ATP-binding pockets.
• This strategy stabilizes the vascular normalization "time window" and prevents resistance.

Conclusions:

• Multiplex inhibition of RTKs is a promising strategy for anti-angiogenic agent discovery.
• This approach addresses the limitations of single-target agents in cancer therapy.
• Novel angiogenesis inhibitors based on this strategy show promising results.